Seelos Therapeutics, Inc.
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
Last updated:
Abstract:
Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
Status:
Grant
Type:
Utility
Filling date:
7 May 2014
Issue date:
3 Dec 2019